to the investor
IN THE MEDIA
Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids.
Cannabics Pharmaceuticals Files Patent Application on Cannabinoid Modulation of the Microbiome
Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells